2m 2m 2m 2m 2m 2m 2m
Vanda Pharma (VNDA)
NASDAQ
$6.07+$0.07 (+1.08%)
Price as of Jul 14, 2026 4:30 AM EDT- $375.2MMarket Cap
- 20.72%1-Year Change
- BiotechnologyIndustry
Vanda Pharma (VNDA)
$6.07+$0.07 (+1.08%)
VNDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.00 | ||
Change | -$0.24 (-3.85%) | ||
Open | $6.15 | ||
High | $6.21 | ||
Low | $5.96 | ||
Previous Close | $6.24 | ||
Volume | 1,168,708 | ||
30-Day Average Volume | 905,593 | ||
1-Week Change | -3.69% | ||
1-Month Change | 2.21% | ||
1-Year Change | 20.72% | ||
3-Year Change | -0.50% | ||
5-Year Change | -69.59% | ||
Fundamentals | |||
Shares Outstanding | 60.1M | ||
Total Assets | $433.5M | ||
Market Cap | $375.2M | ||
Enterprise Value | $321.2M | ||
Period: QTR TTM FY | |||
Revenue | $51.7M | ||
Net Income | -$48.6M | ||
Free Cash Flow | -$50.4M | ||
EBIT | -$48.4M | ||
EBITDA | -$46.4M | ||
Net Working Capital | $157.6M | ||
EPS | -$0.82 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 1 | ||
P/E | -8 | ||
PEG | -0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue